Investor group European Investors-VEB on Wednesday applied for a court inquiry into Philips over allegations of misleading disclosures and management failures linked to the company's recall of sleep apnea devices.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Healthcare technology company Philips announced that it is investing more than $150 million in U.S. manufacturing and research and development facilities.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
PHG's second-quarter 2025 earnings and revenues decline year over year, with macro headwinds and tariffs weighing on the stock.
For any countries that have yet to agree a deal, new tariff rates are due to come into effect on Friday, Aug. 1—though such deadlines have proved to be flexible in the past.
Koninklijke Philips N.V. (NYSE:PHG ) Q2 2025 Earnings Conference Call July 29, 2025 3:00 AM ET Company Participants Charlotte Hanneman - Executive VP, CFO & Member of Board of Management Durga Doraisamy - Corporate Participant Roy Jakobs - President, CEO & Chairman of the Board of Management Conference Call Participants David James Adlington - JPMorgan Chase & Co, Research Division Edward Nicholas Ridley-Day - Redburn (Europe) Limited, Research Division Graham Doyle - UBS Investment Bank, Research Division Hassan Al-Wakeel - Barclays Bank PLC, Research Division Hugo Solvet - BNP Paribas Exane, Research Division Julien Dormois - Jefferies LLC, Research Division Richard Felton - Goldman Sachs Group, Inc., Research Division Veronika Dubajova - Citigroup Inc., Research Division Operator Welcome to the Philips' Second Quarter and Semiannual 2025 Results Conference Call on Tuesday, July 29, 2025.
Shares of health device maker Phillips rallied as much as 14% on Tuesday as the company lifted its earnings guidance despite a hefty hit from tariffs.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
We upgrade Philips to Buy, as litigation overhangs are resolved, FCF inflects positively, and deleveraging is on track. Q1 results show early U.S. recovery, margin resilience, and order book growth, despite China weakness and FX headwinds. Exor's increased stake underscores long-term shareholder confidence.
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) shares soared in Wednesday afternoon's trading, after putting the spotlight on its ongoing collaboration with Philips, The Dutch electronics firm is to broaden its use of Polarean's Xenon lung MRI technology to include younger children with chronic obstructive lung disease, subject to regulatory clearance. Philips said it is integrating the Xenon MRI platform into its 3.0T MRI systems to support non-invasive, radiation-free imaging.